SXI Life Sciences
7.632,83
PKT
-4,77
PKT
-0,06
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.08.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 15.08.12 | Novartis buy | Nomura | |
| 14.08.12 | Straumann hold | Vontobel Research | |
| 10.08.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 10.08.12 | Lonza neutral | J.P. Morgan Cazenove | |
| 30.07.12 | Novartis hold | Vontobel Research | |
| 26.07.12 | Lonza neutral | UBS AG | |
| 26.07.12 | Straumann neutral | UBS AG | |
| 26.07.12 | Lonza hold | Vontobel Research | |
| 26.07.12 | BB Biotech | Close Brothers Seydler Research AG | |
| 25.07.12 | Lonza neutral | Sarasin Research | |
| 25.07.12 | Novartis buy | Nomura | |
| 25.07.12 | Novartis kaufen | Sarasin Research | |
| 25.07.12 | Lonza hold | Vontobel Research | |
| 23.07.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 20.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 20.07.12 | BB Biotech halten | Independent Research GmbH | |
| 20.07.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis buy | Sarasin Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 17.07.12 | Novartis buy | Deutsche Bank AG | |
| 17.07.12 | Novartis buy | Société Générale Group S.A. (SG) | |
| 17.07.12 | Novartis buy | UBS AG | |
| 13.07.12 | BB Biotech kaufen | Independent Research GmbH | |
| 13.07.12 | Novartis buy | Nomura | |
| 13.07.12 | Novartis kaufen | Fuchsbriefe | |
| 12.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Novartis outperform | Credit Suisse Group | |
| 12.07.12 | Novartis hold | Vontobel Research | |
| 12.07.12 | Novartis neutral | Citigroup Corp. | |
| 11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 10.07.12 | Sonova neutral | Sarasin Research |